Bispecific antibodies targeting PD-1 and CTLA-4: new kids on the block(ade) ConferenceESMO 2020 25 November, 2020 12:45
Promising first-in-human trial of epcoritamab in B-NHL Presented ByDr Martin Hutchings, Copenhagen University Hospital, Denmark TrialPhase 1/2, GEN3013 ConferenceEHA 2020 9 September, 2020 12:30
